Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Cardiac Output, Low: early-phase trial registry

2 of 5 indexed Cardiac Output, Low trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Cardiac Output, Low: 5 US clinical trials tracked, 2 recruiting.

Cardiac Output, Low is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Lenox Hill Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition cardiac-output-low

OPEN 2 | RECR 40% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cardiac Output, Low (this)40%
Open-enrollment share among volume-matched conditions near Cardiac Output, Low

Cardiac Output, Low lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cardiac Output, Low on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cardiac Output, Low is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cardiac Output, Low research.

    Lenox Hill Hospital accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Cardiac Output, Low trials plan to enrol fewer than 100 people.

    Median target enrolment is 58 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Cardiac Output, Low splits between interventional and observational designs.

    3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Cardiac Output, Low records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Vitalstream Device
1 trials
Trendelenburg positioning VTI Device
1 trials
Hydrocortisone Drug
1 trials
Nifedipine Drug
1 trials
Atenolol Drug
1 trials
Labetalol Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Cardiac Output, Low trials. A trial with sites in several states counts in each.

West Virginia 1 trials
Texas 1 trials
New York 1 trials
North Carolina 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cardiac Output, Low page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiac Output, Low condition card totals 5 registered trials; most-linked intervention Vitalstream; top US site state West Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.